Tetra Radar · FDA Approvals · Decision date

Ligand Pharmaceuticals Inc: FDA decision date

Ligand Pharmaceuticals Inc (LGND) · 13 April 2026

In January 2026, Travere announced that the FDA had extended the review of the sNDA with a new PDUFA target action date of April 13, 2026.

Source: 10-K of 27 February 2026

The date has passed; Tetra Radar has not recorded an approval.

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.